Sub-Total: $0.00
Hepatocyte Nuclear Factor 4 Alpha in Disease and Drug Discovery
The Hepatocyte Nuclear Factor 4 Alpha (HNF4α)
What is the Hepatocyte Nuclear Factor 4 Alpha (HNF4α)?
The Hepatocyte Nuclear Factor 4 Alpha (HNF4a) belongs to the nuclear receptor superfamily, serving as a critical transcription factor involved in the regulation of gene expression in various tissues, particularly the liver, pancreas, kidney, and intestine. As a master regulator of metabolic pathways, HNF4 plays a pivotal role in maintaining cellular homeostasis and orchestrating physiological processes such as glucose and lipid metabolism, as well as cell differentiation and development.
HNF4α's Role in Human Physiology
The physiological functions of HNF4α span multiple organ systems and metabolic pathways, reflecting its importance in human health and disease. Key roles of HNF4α include:
- Metabolic Regulation: HNF4α governs the expression of genes involved in glucose and lipid metabolism, insulin secretion, and cholesterol homeostasis, contributing to overall metabolic health and energy balance. (1)
- Organ Development and Function: During embryonic development, HNF4α plays a crucial role in organogenesis, particularly in the liver and pancreas, where it regulates the formation and function of hepatocytes and pancreatic β-cells. (2)
- Intestinal Homeostasis: In the intestine, HNF4α regulates the expression of genes involved in nutrient absorption, epithelial barrier function, and intestinal inflammation, thereby influencing gut health and digestive physiology. (3)
- Renal Function: HNF4α is essential for the development and function of renal tubular cells, where it regulates ion transport, fluid balance, and kidney function, highlighting its significance in renal physiology and electrolyte homeostasis. (4)
HNF4α's Role in Disease and Drug Discovery
Given its central role in metabolic regulation and cellular differentiation, dysregulation of HNF4α signaling has been implicated in various diseases, including:
- Diabetes Mellitus: Altered HNF4α activity has been associated with insulin resistance, impaired glucose metabolism, and maturity-onset diabetes of the young, highlighting HNF4α as a potential therapeutic target for diabetes management. (1)
- Liver Disease: HNF4 dysfunction has been linked to liver diseases such as non-alcoholic fatty liver disease (NAFLD) which can progress into liver cirrhosis, and hepatocellular carcinoma (HCC), underscoring its importance in liver health and disease progression. (5)
- Intestinal Disorders: Abnormal HNF4α expression has been observed in inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, suggesting a role for HNF4α in intestinal inflammation and barrier dysfunction. (3)
- Renal Disorders: Mutations in HNF4α genes have been associated with renal cysts and Fanconi syndrome, highlighting its critical role in renal development and function. (4)
INDIGO's HNF4α Reporter Assays
Designed to facilitate research into Hepatocyte Nuclear Factor 4 Alpha signaling and drug discovery, INDIGO Biosciences’ HNF4α Reporter Assay offers a comprehensive platform for evaluating HNF4α activity and screening potential therapeutic compounds. Our assays provide researchers an all-inclusive luciferase reporter system that includes, in addition to HNF4α Reporter Cells, optimized media for use during cell culture and in diluting the user’s test samples, a reference agonist, Luciferase Detection Reagent, and a cell culture-ready assay plate. We can also perform the HNF4α assays in our own lab as a service for researchers.
Our cell-based reporter assays allow scientists to screen and discover drugs that can be used to treat Hepatocyte Nuclear Factor 4 Alpha-related diseases. They provide an efficient way to examine a compound for its ability to regulate receptor activity in agonist, inverse-agonist, or antagonist mode using luciferase reporter gene technology. Since the receptor binding controls the expression of the luciferase reporter gene, luciferase activity in the cells can be correlated directly with the activity of the receptor. INDIGO Biosciences provides comprehensive technical support and expertise to assist researchers in implementing and interpreting HNF4α Reporter Assay results, ensuring reliable and reproducible data. Contact us today to learn more about INDIGO's HNF4α Reporter Assay kits and our screening capabilities!
Works Cited
(1) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC24288/
(2) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600215/
(3) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2435391/
